Showing 11,821 - 11,840 results of 37,919 for search '(( 5 ((ng decrease) OR (mean decrease)) ) OR ( 100 ((nn decrease) OR (a decrease)) ))', query time: 1.09s Refine Results
  1. 11821
  2. 11822
  3. 11823
  4. 11824
  5. 11825

    Individual data 2020. by Luís-Jorge Amaral (16406704)

    Published 2024
    “…Similarly, pNS incidence per 100,000 person-years decreased from 151.7 (95% CI: 112.7–203.4) to 27.0 (95% CI: 12.5–55.5). …”
  6. 11826

    Household data 2022. by Luís-Jorge Amaral (16406704)

    Published 2024
    “…Similarly, pNS incidence per 100,000 person-years decreased from 151.7 (95% CI: 112.7–203.4) to 27.0 (95% CI: 12.5–55.5). …”
  7. 11827

    Persons with epilepsy data 2022. by Luís-Jorge Amaral (16406704)

    Published 2024
    “…Similarly, pNS incidence per 100,000 person-years decreased from 151.7 (95% CI: 112.7–203.4) to 27.0 (95% CI: 12.5–55.5). …”
  8. 11828

    Ivermectin coverage in 2019 and 2021. by Luís-Jorge Amaral (16406704)

    Published 2024
    “…Similarly, pNS incidence per 100,000 person-years decreased from 151.7 (95% CI: 112.7–203.4) to 27.0 (95% CI: 12.5–55.5). …”
  9. 11829

    Individual data 2022. by Luís-Jorge Amaral (16406704)

    Published 2024
    “…Similarly, pNS incidence per 100,000 person-years decreased from 151.7 (95% CI: 112.7–203.4) to 27.0 (95% CI: 12.5–55.5). …”
  10. 11830

    Household data 2020. by Luís-Jorge Amaral (16406704)

    Published 2024
    “…Similarly, pNS incidence per 100,000 person-years decreased from 151.7 (95% CI: 112.7–203.4) to 27.0 (95% CI: 12.5–55.5). …”
  11. 11831

    Persons with epilepsy data 2020. by Luís-Jorge Amaral (16406704)

    Published 2024
    “…Similarly, pNS incidence per 100,000 person-years decreased from 151.7 (95% CI: 112.7–203.4) to 27.0 (95% CI: 12.5–55.5). …”
  12. 11832

    PRISMA flowchart of the included studies. by Gaelle Salame (21077899)

    Published 2025
    “…</p><p>The combined data showed that patients receiving immunotherapy had higher C-peptide levels (Mean Difference (MD) = 1.51; 95% Confidence Interval (CI): [-2.56, 5.58]); however, this difference was not statistically significant (p = 0.42). …”
  13. 11833

    Characteristics of Included Studies. by Gaelle Salame (21077899)

    Published 2025
    “…</p><p>The combined data showed that patients receiving immunotherapy had higher C-peptide levels (Mean Difference (MD) = 1.51; 95% Confidence Interval (CI): [-2.56, 5.58]); however, this difference was not statistically significant (p = 0.42). …”
  14. 11834
  15. 11835
  16. 11836
  17. 11837
  18. 11838
  19. 11839
  20. 11840

    RpoS and Indole Signaling Control the Virulence of <i>Vibrio anguillarum</i> towards Gnotobiotic Sea Bass (<i>Dicentrarchus labrax</i>) Larvae by Xuan Li (137217)

    Published 2014
    “…Deletion of <i>rpoS</i> resulted in increased expression of the indole biosynthesis gene <i>tnaA</i> and in increased production of indole. Both <i>rpoS</i> deletion and the addition of exogenous indole (50–100 µM) resulted in decreased biofilm formation, exopolysaccharide production (a phenotype that is required for pathogenicity) and expression of the exopolysaccharide synthesis gene <i>wbfD</i>. …”